company background image
EXE

ExtendicareTSX:EXE Stock Report

Last Price

CA$7.17

Market Cap

CA$642.2m

7D

-0.4%

1Y

17.2%

Updated

21 Jan, 2022

Data

Company Financials +
EXE fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance1/6
Financial Health1/6
Dividends3/6

EXE Stock Overview

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada.

Price History & Performance

Summary of all time highs, changes and price drops for Extendicare
Historical stock prices
Current Share PriceCA$7.17
52 Week HighCA$8.71
52 Week LowCA$6.06
Beta1.36
1 Month Change0.28%
3 Month Change-0.42%
1 Year Change17.16%
3 Year Change-0.42%
5 Year Change-30.66%
Change since IPO-1.10%

Recent News & Updates

Dec 21
Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Extendicare Inc.'s ( TSE:EXE ) investors are due to receive a payment of CA$0.04 per share on 17th of January. This...

Nov 11
Extendicare (TSE:EXE) Has Re-Affirmed Its Dividend Of CA$0.04

Extendicare (TSE:EXE) Has Re-Affirmed Its Dividend Of CA$0.04

The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.04 per share on the 15th of...

Oct 21
Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Extendicare Inc. ( TSE:EXE ) will pay a dividend of CA$0.04 on the 15th of November. The dividend yield will be 6.6...

Shareholder Returns

EXECA HealthcareCA Market
7D-0.4%-2.4%-2.9%
1Y17.2%-18.4%15.9%

Return vs Industry: EXE exceeded the Canadian Healthcare industry which returned -16.1% over the past year.

Return vs Market: EXE matched the Canadian Market which returned 17.4% over the past year.

Price Volatility

Is EXE's price volatile compared to industry and market?
EXE volatility
EXE Average Weekly Movement2.6%
Healthcare Industry Average Movement10.4%
Market Average Movement9.8%
10% most volatile stocks in CA Market17.4%
10% least volatile stocks in CA Market3.7%

Stable Share Price: EXE is less volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: EXE's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
196823,500Michael Guerrierehttps://www.extendicare.com

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a net of 121 LTC homes and retirement communities, including 69 owned and 52 contract services, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands.

Extendicare Fundamentals Summary

How do Extendicare's earnings and revenue compare to its market cap?
EXE fundamental statistics
Market CapCA$642.16m
Earnings (TTM)CA$27.28m
Revenue (TTM)CA$1.25b

23.5x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EXE income statement (TTM)
RevenueCA$1.25b
Cost of RevenueCA$1.05b
Gross ProfitCA$195.91m
ExpensesCA$168.63m
EarningsCA$27.28m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

Feb 24, 2022

Earnings per share (EPS)0.30
Gross Margin15.70%
Net Profit Margin2.19%
Debt/Equity Ratio409.8%

How did EXE perform over the long term?

See historical performance and comparison

Dividends

6.7%

Current Dividend Yield

158%

Payout Ratio

Does EXE pay a reliable dividends?

See EXE dividend history and benchmarks
When do you need to buy EXE by to receive an upcoming dividend?
Extendicare dividend dates
Ex Dividend DateJan 28 2022
Dividend Pay DateFeb 15 2022
Days until Ex dividend5 days
Days until Dividend pay date23 days

Does EXE pay a reliable dividends?

See EXE dividend history and benchmarks

Valuation

Is Extendicare undervalued compared to its fair value and its price relative to the market?

33.8%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: EXE (CA$7.17) is trading below our estimate of fair value (CA$10.82)

Significantly Below Fair Value: EXE is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: EXE is good value based on its PE Ratio (23.5x) compared to the Canadian Healthcare industry average (34.7x).

PE vs Market: EXE is poor value based on its PE Ratio (23.5x) compared to the Canadian market (13.1x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate EXE's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: EXE is overvalued based on its PB Ratio (5.5x) compared to the CA Healthcare industry average (2.4x).


Future Growth

How is Extendicare forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

-0.2%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if EXE's forecast earnings growth is above the savings rate (1.6%).

Earnings vs Market: Insufficient data to determine if EXE's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: EXE's revenue is expected to decline over the next 3 years (-0.2% per year).

High Growth Revenue: EXE's revenue is forecast to decline over the next 3 years (-0.2% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if EXE's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Extendicare performed over the past 5 years?

1.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: EXE has a large one-off loss of CA$43.0M impacting its September 30 2021 financial results.

Growing Profit Margin: EXE's current net profit margins (2.2%) are lower than last year (2.8%).


Past Earnings Growth Analysis

Earnings Trend: EXE's earnings have grown by 1.6% per year over the past 5 years.

Accelerating Growth: EXE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: EXE had negative earnings growth (-13.3%) over the past year, making it difficult to compare to the Healthcare industry average (-10.6%).


Return on Equity

High ROE: Whilst EXE's Return on Equity (23.49%) is high, this metric is skewed due to their high level of debt.


Financial Health

How is Extendicare's financial position?


Financial Position Analysis

Short Term Liabilities: EXE's short term assets (CA$231.4M) do not cover its short term liabilities (CA$304.5M).

Long Term Liabilities: EXE's short term assets (CA$231.4M) do not cover its long term liabilities (CA$488.4M).


Debt to Equity History and Analysis

Debt Level: EXE's net debt to equity ratio (295.9%) is considered high.

Reducing Debt: EXE's debt to equity ratio has increased from 254.8% to 409.8% over the past 5 years.

Debt Coverage: EXE's debt is not well covered by operating cash flow (19.2%).

Interest Coverage: EXE's interest payments on its debt are well covered by EBIT (4.5x coverage).


Balance Sheet


Dividend

What is Extendicare current dividend yield, its reliability and sustainability?

6.69%

Current Dividend Yield


Upcoming Dividend Payment

TodayJan 22 2022Ex Dividend DateJan 28 2022Dividend Pay DateFeb 15 202218 days from Ex DividendBuy in the next 5 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: EXE's dividend (6.69%) is higher than the bottom 25% of dividend payers in the Canadian market (1.6%).

High Dividend: EXE's dividend (6.69%) is in the top 25% of dividend payers in the Canadian market (4.64%)


Stability and Growth of Payments

Stable Dividend: EXE's dividends per share have been stable in the past 10 years.

Growing Dividend: EXE's dividend payments have fallen over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (158.3%), EXE's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: EXE's dividends in 3 years are not forecast to be well covered by earnings (575.6% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.0yrs

Average management tenure


CEO

Michael Guerriere (57 yo)

3.25yrs

Tenure

CA$1,713,124

Compensation

Dr. Michael R. Guerriere, MD, MBA, has been the Chief Executive Officer and President at Extendicare Inc. since joined in October 22, 2018. Dr. Guerriere serves as Chairman and Chief Executive Officer of E...


CEO Compensation Analysis

Compensation vs Market: Michael's total compensation ($USD1.37M) is above average for companies of similar size in the Canadian market ($USD796.65K).

Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: EXE's management team is considered experienced (2 years average tenure).


Board Members

Experienced Board: EXE's board of directors are considered experienced (6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Extendicare Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Extendicare Inc.
  • Ticker: EXE
  • Exchange: TSX
  • Founded: 1968
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: CA$642.163m
  • Shares outstanding: 89.56m
  • Website: https://www.extendicare.com

Number of Employees


Location

  • Extendicare Inc.
  • 3000 Steeles Avenue East
  • Suite 103
  • Markham
  • Ontario
  • L3R 4T9
  • Canada

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/21 23:38
End of Day Share Price2022/01/21 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.